0000921895-21-000543.txt : 20210223 0000921895-21-000543.hdr.sgml : 20210223 20210223175925 ACCESSION NUMBER: 0000921895-21-000543 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210219 FILED AS OF DATE: 20210223 DATE AS OF CHANGE: 20210223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Donaldson Michael Paul CENTRAL INDEX KEY: 0001824022 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36866 FILM NUMBER: 21667159 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics Inc. CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-514-7149 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Summit Therapeutics plc DATE OF NAME CHANGE: 20150219 FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 4 1 form412566don_02232021.xml OWNERSHIP DOCUMENT X0306 4 2021-02-19 0 0001599298 Summit Therapeutics Inc. SMMT 0001824022 Donaldson Michael Paul C/O SUMMIT THERAPEUTICS INC., ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 3.52 2021-02-19 4 D 0 5110 D 2030-06-08 Common Stock 5110 594890 D Represents the forfeiture of performance-based stock options granted to the Reporting Person on June 8, 2020 that were eligible to vest based on certain performance conditions. Upon grant, the target vesting amount was reported in Table II of Form 3. On February 19, 2021, the Compensation Committee of the Board of Directors of the Issuer determined that, based on the Issuer's performance over the applicable performance period, 37,129 shares would vest and 5,110 shares would be forfeited. As of February 19, 2021, a total of 79,368 shares have vested and 515,522 shares remain eligible to vest from this grant. Not applicable. /s/ Michael Paul Donaldson, Attorney-in-Fact 2021-02-23